Evolving Concepts in the Management of Newly Diagnosed Epithelial Ovarian Cancer von Gourley, Charlie, Bookman, Michael A

Volltext

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline von Wright, Alexi A, Bohlke, Kari, Armstrong, Deborah K, Bookman, Michael A, Cliby, William A, Coleman, Robert L, Dizon, Don S, Kash, Joseph J, Meyer, Larissa A, Moore, Kathleen N, Olawaiye, Alexander B, Oldham, Jessica, Salani, Ritu, Sparacio, Dee, Tew, William P, Vergote, Ignace, Edelson, Mitchell I

Volltext

First-line Chemotherapy in Epithelial Ovarian Cancer von BOOKMAN, MICHAEL A

Volltext

Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer von Meyer, Larissa A, Cronin, Angel M, Sun, Charlotte C, Bixel, Kristin, Bookman, Michael A, Cristea, Mihaela C, Griggs, Jennifer J, Levenback, Charles F, Burger, Robert A, Mantia-Smaldone, Gina, Matulonis, Ursula A, Niland, Joyce C, O'Malley, David M, Wright, Alexi A

Volltext

Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer von Wright, Alexi A, Cronin, Angel, Milne, Dana E, Bookman, Michael A, Burger, Robert A, Cohn, David E, Cristea, Mihaela C, Griggs, Jennifer J, Keating, Nancy L, Levenback, Charles F, Mantia-Smaldone, Gina, Matulonis, Ursula A, Meyer, Larissa A, Niland, Joyce C, Weeks, Jane C, O'Malley, David M

Volltext

Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis von Simon, Lee S., Grierson, Lisa M., Naseer, Zahid, Bookman, Arthur A.M., Zev Shainhouse, J.

Volltext

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study von Ferriss, James S, Java, James J, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Walker, Joan L, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew P, Burger, Robert A

Volltext

Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer – an ancillary data analysis of the VELIA trial von Aghajanian, Carol, Swisher, Elizabeth M., Okamoto, Aikou, Steffensen, Karina Dahl, Bookman, Michael A., Fleming, Gini F., Friedlander, Michael, Moore, Kathleen N., Tewari, Krishnansu S., O'Malley, David M., Chan, John K., Ratajczak, Christine, Hashiba, Hideyuki, Wu, Meijing, Dinh, Minh H., Coleman, Robert L.

Volltext

Content Validity of Sjögren’s Syndrome Symptom Diary and Functional Assessment of Chronic Illness Therapy-Fatigue in Patients with Sjögren’s von Griffiths, Natasha, Wratten, Samantha, Flynn, Jessica, Bookman, Arthur A. M., Ndife, Briana, Hueber, Wolfgang, Goswami, Pushpendra

Volltext

Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study von BURGER, Robert A, BRADY, Mark F, LIM, Peter C, RUBIN, Stephen C, KATSUMATA, Noriyuki, LIANG, Sharon X, BOOKMAN, Michael A, MONK, Bradley J, WALKER, Joan L, HOMESLEY, Howard D, FOWLER, Jeffrey, GREER, Benjamin E, BOENTE, Matthew, FLEMING, Gini F

Volltext

The addition of new drugs to standard therapy in the first-line treatment of ovarian cancer von Bookman, M A

Volltext

Second‐Line Treatment of Ovarian Cancer von Markman, Maurie, Bookman, Michael A.

Volltext

Update of randomized trials in first-line treatment von Bookman, Michael A

Volltext

Whole stimulated salivary flow: Correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens from patients with primary Sjögren's syndrome but... von Bookman, Arthur A. M., Shen, Hua, Cook, Richard J., Bailey, Denis, McComb, R. John, Rutka, John A., Slomovic, Allan R., Caffery, Barbara

Volltext

Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study von Horowitz, Neil S., Larry Maxwell, G., Miller, Austin, Hamilton, Chad A., Rungruang, Bunja, Rodriguez, Noah, Richard, Scott D., Krivak, Thomas C., Fowler, Jeffrey M., Mutch, David G., Van Le, Linda, Lee, Roger B., Argenta, Peter, Bender, David, Tewari, Krishnansu S., Gershenson, David, Java, James J., Bookman, Michael A.

Volltext

Speeding up the Evaluation of New Agents in Cancer von Parmar, Mahesh K. B., Barthel, Friederike. M.-S., Sydes, Matthew, Langley, Ruth, Kaplan, Rick, Eisenhauer, Elizabeth, Brady, Mark, James, Nicholas, Bookman, Michael A., Swart, Ann-Marie, Qian, Wendi, Royston, Patrick

Volltext

In Accordance With Our Best Estimates von Bookman, Michael A

Volltext

Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin... von BOOKMAN, M. A, MALMSTRÖM, H, BOLIS, G, GORDON, A, LISSONI, A, KREBS, J. B, FIELDS, S. Z

Volltext

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer von Coleman, Robert L, Fleming, Gini F, Brady, Mark F, Swisher, Elizabeth M, Steffensen, Karina D, Friedlander, Michael, Okamoto, Aikou, Moore, Kathleen N, Efrat Ben-Baruch, Noa, Werner, Theresa L, Cloven, Noelle G, Oaknin, Ana, DiSilvestro, Paul A, Morgan, Mark A, Nam, Joo-Hyun, Leath, Charles A, Nicum, Shibani, Hagemann, Andrea R, Littell, Ramey D, Cella, David, Baron-Hay, Sally, Garcia-Donas, Jesus, Mizuno, Mika, Bell-McGuinn, Katherine, Sullivan, Danielle M, Bach, Bruce A, Bhattacharya, Sudipta, Ratajczak, Christine K, Ansell, Peter J, Dinh, Minh H, Aghajanian, Carol, Bookman, Michael A

Volltext

Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerab... von Mease, P J, Hobbs, K, Chalmers, A, El-Gabalawy, H, Bookman, A, Keystone, E, Furst, D E, Anklesaria, P, Heald, A E

Volltext